Royalty as a percentage of net sales
United Therapeutics·Products & Services·5 segments
Breakdown
Segments
IVIVA kidney productsView metric
AdcircaView metric
Tyvaso DPIView metric
UHeart, UKidney, and UThymoKidneyView metric
UnituxinView metric
| Segment | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Adcirca | — | — | 10% | 10% | 10% |
| Tyvaso DPI | — | — | 10% | 10% | 10% |
| Unituxin | 1% | 1% | 1% | 1% | 1% |
| Total | — | — | 2% | 2% | 2% |
All segment values are derived from annual filings.